The most awaited #BreastCancer data presented at #ASCO24 by @curijoey (@AIOMtweet board & @myESMO council member): #TDXd significantly improves PFS and ORR as first chemotherapy line in HR /HER2- disease progressing on ET with very interesting signal in HER2ultralow @OncoAlert

. Hyper Productive Authors We are going to take a look at #HyperProductiveAuthors. Here are some thoughts to get us started: ⭕️The image shows a @Nature news item by @gvconroy. You can see the full article at nature.com/articles/d41586-0… ⭕️We have looked at this area before but, unfortunately, never hash tagged them so that they could be grouped together. As an example, we have tweeted about Sayed Mohamed Eldin and we'll certainly take another look at this hyper productive author in the near future. You can see some of our previous posts on Eldin by following this link: x.com/search?q="Sayed Moha… ⭕️It would be interesting to know what you think of hyper productive authors. Q: If somebody is publishing (say) one paper a week, is that necessarily, or always, a bad thing? Or to put the question another way, Q: Is it possible to publish one paper a week in a way that would be considered ethical/acceptable? ⭕️There are more articles in the peer reviewed scientific literature on this topic that we'll feature some of these as this mini series of posts unfolds. If you know of any articles, please let us know. ⭕️For the purposes of these posts, we'll use the measure that a hyper productive author is somebody who publishes more than one paper a week, so about 50 a year. We won't be too beholden to that figure else we'll start getting into debates about work days, weekends, public holidays etc. So, let's go with about 50 papers a year as a rough measure but let's not not get too focused on the numbers as an absolute measure. ⭕️If you have any ideas for authors that we should take a look at, please let us know. The more information you can provide the better. For example, their Google Scholar profile, their full name, their institution, a sample paper etc. If you don't want to comment here, then please DM us. ⭕️As we have done above, we'll tag each of these posts with the hashtag #HyperProductiveAuthors, so that we can find them again. We hope you find this series of posts interesting.

Really interesting survey when prolific authors were asked whether they met the criteria for being an author | @Nature | #HyperProductiveAuthors | @Sarahho46301724 | @KevinBoyack | buff.ly/3WVlli4

"Saudi Arabia had the highest number of extremely productive authors among the countries that have seen the fastest growth. However, Thailand had the sharpest increase between 2016 and 2022 " buff.ly/3VgYtrd | @Nature | @gvconroy | #HyperProductiveAuthors

"The scientists who publish a paper every five days" | @Nature | #HyperProductiveAuthors | @Sarahho46301724 | @KevinBoyack | buff.ly/3WVlli4

Number of ‘extremely productive’ authors concerns scientists buff.ly/3VgYtrd | @Nature | @gvconroy | #HyperProductiveAuthors

"MDPI journal undergoing reevaluation at Scopus, indexing on hold" | @RetractionWatch | #MDPIPublisher | @Scopus | @Sus_MDPI | buff.ly/48ArTW4

Several million $ from universities worldwide (which in 🇮🇹 means from citizen’s taxes) are being used every year for paying MDPI journals APC. The question whether these journals are predatory or not is not only merely academic, but also one with relevant economic repercussions.

Congrats @curijoey ands best wishes for your next adventure!

Soft tissue tumors –updates& notable changes: Basic facts for residents (Part 1) #MakeSurgiPathEasy #SoftTissueTumorPart1

Easy case to start the week - DCIS with microinvasion...but how many foci? 😃#breastpath @atman_ci @DrGeeONE @ADamronMD @QassidO @Cristina_VargAP @fouad_boulos @kis_lorand @LizaMQuintana @MBBS_Pathology @tlabiano @A_Morini_MD @ariella8 @nusrat_xahra @amalasar86 @gonzadetoro

What will we do Monday morning? My take home points from #SABCS22 - limiting and oversimplifying an incredible amount of high-quality research to fit in a few slides @OncoAlert #bcsm @SABCSSanAntonio

Sponsored by @Roche, I would like to share a Tweetorial about recent important advances in the management of advanced/metastatic triple negative breast cancer (mTNBC) #Tweetorial #Oncology #Cancer #Diagnosis #TNBC #Immunotherapy #PDL1

Do osteoclast-like stromal giant cells in breast cancer belong to the spectrum of tumor-associated macrophages?➡️frontiersin.org/articles/10.… Many thanks to:@NicolaFuscoMD @KonVenetis and all other collaborators @IEOufficiale @LaStatale @4oncommunity @FrontMolBioSci

If needed, here I am: #breastpath addicted

Sad news! Great loss for the scientific community. RIP, Ondra! Deep condolences to the family

We’re pleased to announce our new impact factor of 50.717‼️ Thank you to our authors and reviewers! #JCO #OncTwitter

Free access link to our recent @JAMAOnc publication on HER2-low breast cancer! 👇 jamanetwork.com/journals/jam…

Great team, great job, great results proud to be part of such terrific group #breastcancer

Terrific! Congrats to all of You 👏🏼